Viruses in the family Coronaviridae, with the Nidovirus order, are etiologic agents of a range of 25 human and animal diseases, including both mild and severe respiratory disease in humans. 26
Importance 50
Viruses in the family Coronaviridae include important human and animal pathogens, including 51 the recently emerged SARS-CoV and MERS-CoV. We have shown previously that two viruses 52 within the genus Betacoronavirus murine coronavirus (MHV) and MERS-CoV, encode 2',5' 53 phosphodiesterases (PDEs) that antagonize the OAS-RNase L pathway and report here that 54 these proteins are furthermore conserved among additional coronavirus superfamily members 55 including lineage A betacoronaviruses and toroviruses and suggesting they may play critical 56 roles in pathogenesis. As there are no licensed vaccines or effective antivirals against human 57 coronaviruses and few against those infecting animals, identifying viral proteins contributing to 58 virulence can inform therapeutic development. Thus, this work demonstrates that a potent 59 antagonist of host antiviral defenses is encoded by multiple and diverse viruses within 60 Introduction 62 63
Coronaviruses (CoV) and closely related toroviruses (ToV) are well known agents of disease in 64 mammals, including humans. Coronaviruses and toroviruses, members of the family 65
Coronaviridae, within the Nidovirus order, contain positive sense single stranded (ss)RNA 66 genomes, the longest known RNA genomes ranging from 28-31kb (1) . The first two thirds of 67 their genomes encodes the replicase proteins, which include the viral RNA-dependent RNA 68 polymerase and numerous non-structural proteins (NSPs), which are required for replication 69 and in some cases have host immune antagonist activities (2) 70
. The structural proteins are encoded in the 3' third of the genome and consist of spike (S), 71 small membrane protein (E), membrane (M), nucleocapsid (N) and sometimes hemagglutinin-72 esterase (HE). Interspersed among the structural genes are diverse genes encoding accessory 73 proteins that are not essential for replication but are believed to be required for virulence in vivo 74 (1) . 75 76 Mouse hepatitis virus (MHV) is a lineage A Betacoronavirus and the prototypical CoV. MHV 77 encodes the accessory protein NS2 which was previously identified as a 2-His (H) 78 phosphoesterase (2H-PE) superfamily member (3) that we have demonstrated has 2',5'-79 phosphodiesterase (PDE) activity that antagonizes host interferon (IFN) signaling via 80 antagonism of the 2',5'-oligoadenylate synthetase (OAS)-ribonuclease (RNase) L pathway (4). 81
Upon sensing double stranded (ds)RNA, OAS synthesizes 2',5'-oligoadenylates (2-5A) which 82 catalyze the activation of RNase L via homodimerization. RNase L subsequently cleaves host 83 and viral ssRNA leading to termination of protein synthesis and subsequent apoptosis (5). NS2 84 cleaves 2-5A thus preventing the activation of RNase L. NS2 is a critical determinant of MHV 85 strain A59 (A59) liver tropism in C57Bl/6 (B6) mice and is required for the virus to cause 86 phosphodiesterase is unable to antagonize the OAS-RNase L pathway in the liver of mice. 88 Infection with this virus does not result in hepatitis and NS2 Mut replication is reduced at least 89 10,000 fold compared to wild-type A59. However, in mice genetically deficient for RNase L 90 (RNase L -/-) NS2 Mut replicates to wild-type levels and causes hepatitis (4). 91
92
As might be expected of antagonists of a potent innate antiviral pathway, 2',5' PDEs are not a 93 host evasion mechanism unique to MHV. We recently showed that the NS4b accessory protein 94 of MERS-CoV and related bat coronaviruses, all lineage C betacoronaviruses, encode the NS4b 95 accessory proteins with 2',5'-PDE activity (6). Additionally, unrelated group A rotaviruses 96 encode a PDE in the C-terminal domain of the VP3 structural protein (7). We show here that 97 lineage A betacoronaviruses closely related to MHV, including the human respiratory HCoV-98 OC43 (OC43), human enteric CoV-4408 (HECoV), equine ECoV-NC99 (ECoV), and porcine 99 hemagglutinating encephalomyelitis virus (PHEV), as well as the more distantly related equine 100 torovirus (EToV)-Berne (BEV) also encode NS2 homologs with predicted PDE activity. We 101 found that these proteins do possess enzymatic 2',5'-PDE activity that is capable of 102 antagonizing RNase L (with the exception of the PHEV NS2) and thus countering a potent host 103 antiviral response, suggesting that PDE mediated OAS-RNase L antagonism is an important 104 virulence strategy for lineage A betacoronaviruses and toroviruses. 105 106 Material and Methods 107 experiments involving mice were approved by the Institutional Animal Care and Use Committee 114 at the University of Pennsylvania. Primary bone marrow derived macrophages (BMM) were 115 derived from marrow harvested from the hind limbs (tibia and femur) of four to six week old B6 116 or RNase L -/mice as described previously (4,11). Cells were cultured in DMEM (Gibco) 117 supplemented with 10% FBS (Hyclone) and 20% L929 cell-conditioned media for 6 days before 118 infection. 119 120 Plasmids. NS2 genes from lineage A betacoronaviruses OC43, HECV-4408, ECoV-NC99 121 NC99, PHEV and pp1a-carboxyterminal domain (CTD) from the torovirus Berne were 122 synthesized and cloned into pUC57 by BioBasic yielding pUC-OC43NS2, pUC-HECVNS2, 123 pUC-ECoVNS2, pUC-PHEVNS2 and pUC-pp1a. The second catalytic His to Arg substitutions 124 were made by site directed mutagenesis in all plasmids resulting in pUC-OC43NS2 H129R , pUC-125 HECVNS2 H129R , pUC-NC99NS2 H129R , pUC-PHEVNS2 H129R and pUC-pp1a H4516R . Select genes 126 were subsequently subcloned into the pMal parallel-2 expression vector resulting in pMAL-127 OC43NS2, pMAL-OC43NS2 H129R , pMAL-PHEVNS2, pMAL-PHEVNS2 H129R , pMAL-pp1a and 128 pMAL-pp1a H4516R . MHV NS2 and NS2 H129R had been previously cloned into pMAL-c2 (4). 129 HEPES [pH 7.2], 10 mM MgCl 2 , 1 mM dithiothreitol) were incubated at 30° with (2'-5')p 3 A 3 (2-140 5A). After one hour, reactions were stopped by heat inactivation at 95° for 3 min followed by 30 141 min centrifugation at 20,000 X g (4°) and supernatants carefully removed. A fluorescent 142 resonance energy transfer (FRET) assay was used to assess enzymatic activity by measuring 143 the amount of uncleaved, intact 2-5A left in the reaction, as previously described (13). The 144 abilities of recombinant enzyme to degrade 2-5A were determined by a FRET based RNase L 145 activation assay using an authentic 2-5A (2',5'-p 3 A 3 ) trimer as described earlier (4, 6, 13, 14). 146
Assays were performed three times in triplicate using two separate enzyme preparations. 147 148 Viruses and chimeric recombinant virus construction. Wild-type MHV strain A59 and 149 mutant NS2 H126R (referred to as MHV and MHV Mut in the data shown herein) were described 150 previously (14). The chimeric viruses were constructed based on the infectious cDNA clone 151 icMHV-A59 (8,15). The wild-type and mutant PDEs genes were PCR amplified from the pUC 152 plasmids constructed above with primers bearing SalI and NotI restricting sites. After purification 153 and digestion with SalI and NotI, the fragments were cloned into icMHV-A59 fragment G, with 154 an NS2 H126R mutation, as previously described (14), and confirmed by DNA sequencing. The 155 full-length A59 genome cDNA was assembled, and the recombinant viruses were recovered in 156 BHK-R cells as previously described (8, 14, 15) acid sequence of these proteins into Phrye 2 to predict their tertiary structures (Fig 2) . All of 218 these proteins scored highly for homology with the published structure of the A-kinase 219 anchoring protein 7 (AKAP7) central domain (CD) (18), a previously identified host-encoded 2H-220 PE with 2',5'-PDE (7). We have previously shown that the MHV NS2 and group A rotavirus 221 (RVA) VP3 proteins, also structural homologs of AKAP7 CD, exhibit 2',5' PDE activity and can 222 antagonize RNase L (4,7,14). 
Exogenous coronavirus and torovirus PDEs rescue replication of MHV Mut in primary B6 262

BMMs through inhibition of RNase L activation. To determine if the exogenous PDEs can 263
antagonize RNase L in the context of infection, we infected BMMs from WT B6 and RNase L -/-264 mice with MHV, MHV Mut and the chimeric viruses and measured replication by plaque assay at 265 6, 9, 12, and 24 hpi. As expected, MHV Mut is significantly attenuated in WT BMMs but replicates 266 to equivalent titers as MHV in RNase L -/-BMMs ( Fig 6A) . All of the chimeric viruses encoding 267 WT exogenous PDEs from OC43, HECoV, ECoV and BeV, replicated to a similar extent as WT 268 on December 27, 2016 by UNIV OF CALIF SAN DIEGO http://jvi.asm.org/ Downloaded from A59 in B6 BMMs, indicating that these proteins effectively compensate for an inactive NS2 H126R 269 in MHV (Fig 4B-E) . In contrast, and similarly to MHV Mut , the chimeras expressing catalytically 270 inactive exogenous PDEs fail to replicate robustly in B6 BMMs but do replicate efficiently in 271
RNase L -/-BMMs (Fig 6A-E) . The chimeric virus encoding PHEV NS2 were not assessed for 272 replication in BMMs due to our inability to confirm its expression ( Figure 5 ). 273
274
To directly link antagonism of RNase L to the ability of the exogenous PDEs to rescue MHV Mut 275 replication, we assessed rRNA degradation in infected cells by Bioanalyzer. We have previously 276 used this assay to demonstrate that MHV NS2, but not NS2 H126R , inhibits RNase L-mediated 277 RNA degradation, and that a deficiency in RNase L obviates the requirement for NS2 in MHV 278 replication (4). We infected B6 WT and RNase L -/-BMMs with MHV and the chimeric viruses and 279 harvested total RNA 9 hpi. We ran the total RNA on a Bioanalyzer to visualize the integrity of 280 rRNA during infection with MHV and the chimeric viruses. MHV and the chimeric viruses 281 encoding exogenous PDEs encoded by MHV, OC43, HECoV, ECoV and BEV prevented rRNA 282 degradation in B6 WT BMMs, while the corresponding catalytically inactive PDEs failed to do so 283 ( Fig 6F) . This directly links the ability of the exogenous PDEs to rescue MHV Mut replication to 284 their antagonism of RNase L activation. 285 286 OC43 NS2 and BEV pp1a-CTD restore MHV Mut replication and pathogenesis in vivo. MHV 287 causes profound hepatitis and associated liver pathology in B6 mice, with its liver replication 288 and pathogenesis dependent on NS2-mediated antagonism of RNase L (Fig 7) (4). To 289 determine whether exogenous viral PDEs can rescue replication and restore pathogenesis to 290 MHV Mut , we infected B6 and RNase L -/mice with MHV, MHV Mut and the chimeric viruses 291 expressing either WT or catalytic mutant PDEs from OC43 (NS2) and BEV (pp1a-CTD). Five 292 days post-infection, at the time of peak titer, the mice were sacrificed and livers harvested for 293 virus titration by plaque assay. In WT B6 mice chimeric viruses expressing either WT OC43 294 on December 27, 2016 by UNIV OF CALIF SAN DIEGO http://jvi.asm.org/ Downloaded from NS2 or BEV pp1-CTD replicated robustly in the liver, similarly to MHV. In contrast, and like 295 MHV Mut , the chimeric viruses expressing mutant OC43 NS2 ( Fig 7B) or BEV pp1a-CTD ( Fig 7C)  296 are dramatically restricted, replicating only to titers below or just above the limit of detection, 297 whereas all of the chimeric viruses replicated robustly in the livers of RNase L -/mice (Fig 7A-C) . 298
299
To assess hepatitis in these infected mice, livers sections were assessed for viral antigen and 300 pathological changes. Like A59, chimeric viruses expressing WT OC43 NS2 or BEV pp1a-CTD 301 caused hepatitis in B6 mice, indicated by pathologic foci in H&E stained livers, with viral antigen 302 staining widely observed (Fig 7D,E) . Chimeric viruses expressing catalytically inactive OC43 303 NS2 or BEV pp1a-CTD did not cause liver pathology in B6 mice and viral antigen was absent, 304 consistent with the lack of replication (Fig 7D,E) . In RNase L -/mice, all of the chimeric viruses 305 replicated robustly and caused pathology similar to MHV A59 (Fig 7D,E) , further demonstrating 306 that the restriction of the viruses expressing mutant PDEs in B6 mice is RNase L-mediated and 307 that the exogenous PDEs function equivalently to MHV NS2. 308 309
Discussion 310
We have previously demonstrated 2-5A cleavage and RNase L antagonism by 2',5' PDEs 311 encoded by a lineage A and a lineage C betacoronavirus (MHV and MERS-CoV respectively) 312 and group A rotaviruses as well as by cellular AKAP7 CD (4,6,7,14). Here, we extend these 313 findings to show that additional lineage A betacoronaviruses as well as a related torovirus family 314 member encode 2',5' PDEs capable of antagonizing RNase L by cleaving 2-5A. The presence 315 of genes encoding these proteins in multiple lineage A betacoronaviruses suggests that this 316 gene was acquired by an ancient common ancestor of this lineage. Whether this virus was also 317 ancestral to toroviruses and lineage C betacoronaviruses, or whether 2',5' PDEs were acquired 318 by viruses in multiple independent events is unclear. The maintenance of this highly conserved 319 protein throughout lineage A betacoronaviruses supports the idea that this protein mediates an 320 on December 27, 2016 by UNIV OF CALIF SAN DIEGO http://jvi.asm.org/ Downloaded from essential function in the diverse natural hosts of these viruses, spanning multiple mammalian 321 families. Our finding of a homologous PDE in some groups of rotaviruses (14), a virus family, 322 unrelated to coronaviruses is intriguing. A coronavirus recently isolated from bats was found to 323 encode a protein likely to have originated from a bat orthoreovirus, which like rotaviruses has a 324 dsRNA genome, suggesting the possibility of recombination between coronavirus and a dsRNA 325 virus (20). Further support for this idea comes from a recent report of isolation of a MERS like 326 coronavirus and a rotavirus in the feces of Korean bats (21). Additionally, the viruses encoding 327 the PDEs we have described here infect different tissues within their hosts (1, 22, 23) , indicating 328 that RNase L antagonism may be required for robust replication in diverse cell types. For 329 example, although MHV is hepatotropic, OC43 infects the upper airway, while other PDEs 330 described here are encoded by enterotropic viruses (1, 22, 23) . 331
332
The PDEs encoded by OC43, HECoV, ECoV and BEV antagonized RNase L and rescued 333 replication of MHV Mut in primary WT B6 BMMs, indicating that not only are they enzymatically 334 active 2',5' PDEs, but that they functionally compensate for an inactive MHV NS2 (Fig 3,6,7) . 335
Interestingly the BEV encoded PDE was able to antagonize RNase L and rescue virus MHV Mut 336 replication both in vitro and in vivo despite the apparently low level of expression ( Fig 5,6,7) . 337 This is not surprising as MERS NS4b PDE can rescue MHV Mut despite its very low expression 338 level in the cytoplasm (6). PHEV NS2, is less enzymatically active than the other PDEs (Fig 3) , 339 suggesting it may be less able to antagonize RNase L. However since we could not detect 340 expression by western blot of the PHEV PDE from a chimeric virus (Fig 5) , further work will be 341 needed to determine if it has RNase L antagonist activity in the context of an infection. 
